Screener
Cytek Biosciences, Inc. CTKB Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Cytek Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s current ratio?
- Cytek Biosciences, Inc. (CTKB) reported current ratio of 4.5× in Q2 2026.
- How has Cytek Biosciences, Inc.'s current ratio changed year-over-year?
- Cytek Biosciences, Inc.'s current ratio decreased by 14.2% year-over-year, from 5.2× to 4.5×.
- What is the long-term trend for Cytek Biosciences, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s current ratio has grown at a -8.5% compound annual growth rate (CAGR), from 7.9× to 5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Cytek Biosciences, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude